Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is expected to disclose its quarterly earnings on April 3, 2025, with estimates showing an EPS of $0.53 and revenues nearing $37.9 billion.

• Ongoing Legal Challenges: The company is involved in a class action lawsuit regarding securities fraud, which may adversely impact investor confidence.

As a major player in retail and wholesale pharmacy globally, Walgreens faces tough competition from companies like CVS Health. The anticipated earnings release comes as the company deals with significant operational issues.

Analysts expect Walgreens to report EPS of around $0.53, alongside revenues of approximately $37.9 billion. The ongoing lawsuit alleging securities fraud, which claims misleading statements regarding compliance, adds to the pressure.

Investors will be keenly watching the earnings report as the outcome of the lawsuit is set to influence shares and overall investor sentiment. The current tight market environment could complicate Walgreens’ financial recovery.